← Files Investment BankingARCHIVED FILE
skills/buyer-investor-list/references/qa-checklist.md
3.53 KB · Oct 5, 2026 · 18:28 UTC
# MD Review QA Checklist Run this checklist before finalizing output. ## Completeness - Are all relevant archetypes covered for the mandate? - Are obvious strategics, sponsors, platforms, lenders, or investors included or explicitly excluded? - Are existing lenders/shareholders/prior process participants considered when relevant? - Are sponsor-backed platforms mapped, not just sponsor names? - Are cross-border, family office, permanent capital, infrastructure, credit, or distressed buyers considered only where relevant? ## Relevance - Does every tier 1 party have specific rationale? - Are any names included only because they are large, famous, or broadly tagged to the sector? - Does each party fit the transaction size, geography, sector, stage, and structure? - Are stale or weakly supported parties labeled as watchlist/validate? ## Ability to transact - Can each tier 1 party plausibly pay, finance, invest, or hold the required amount? - Are fund size, vintage, mandate, check size, and control/minority fit considered for sponsors? - Are hold size, lead capability, sector appetite, and documentation speed considered for lenders? - Is aum avoided as a proxy for dry powder or check size unless supported? ## Process risk - Are confidentiality-sensitive competitors flagged? - Are antitrust/regulatory flags included where obvious? - Are portfolio conflicts and commercial relationship sensitivities checked? - Are leak/retrade/bad-process reputation issues reflected if known? - Are client do-not-contact instructions respected? ## Outreach strategy - Are waves logical given valuation, certainty, and confidentiality objectives? - Is the teaser/nda/named-disclosure approach clear? - Are client approval gates explicit? - Is there a relationship owner or contact validation ask for priority parties? - Does the output identify who an MD should call personally? ## Data quality - Are parent/subsidiary/sponsor/platform duplicates resolved? - Are prior notes, nda status, iois/lois, and outreach history preserved? - Are sources and confidence levels included? - Are facts, assumptions, and inferences separated? - Are missing fields identified without hallucinating? ## Final "so what" - Does the output clearly recommend who to contact first and why? - Does it identify who not to contact and why? - Does it explain how the list creates competitive tension or improves certainty? - Could an MD defend this list in front of a client or committee? ## Standalone HTML Presentation - Does an HTML-selected output follow `../../../references/html-artifact-standard.md` as a polished standalone buyer-universe report? - Does the first viewport make the process posture, conditional first wave, high-value holds, and required approvals clear? - Is there one central ranked universe table rather than several overlapping retellings of the same decision? - Are held or excluded sensitive parties handled in the dedicated hold register rather than duplicated as full ranked-table rows, unless comparison is essential? - Are pre-outreach validation and diligence gates consolidated into one actionable table? - Are numerical scores demoted unless they materially explain prioritization or were requested? - Are citations readable at the claim or row level rather than repeated across every cell? - Are generic dashboard navigation, reader-action bars, related-file panels, internal contracts, and other visible generation machinery absent unless specifically useful and requested? - Has the local HTML been rendered and visually inspected with local headless-browser screenshots before delivery?
SHA-256: 2887dcc972d794f89d813f0c1b6388dac50527d6b0f01e7317a2dfb6216e144f